CN111413327A - 双模式检测***和双模式检测方法 - Google Patents
双模式检测***和双模式检测方法 Download PDFInfo
- Publication number
- CN111413327A CN111413327A CN202010347511.6A CN202010347511A CN111413327A CN 111413327 A CN111413327 A CN 111413327A CN 202010347511 A CN202010347511 A CN 202010347511A CN 111413327 A CN111413327 A CN 111413327A
- Authority
- CN
- China
- Prior art keywords
- afterglow
- turbidimetric
- analyte
- reaction cup
- detection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000001514 detection method Methods 0.000 title claims abstract description 245
- 230000009977 dual effect Effects 0.000 title claims abstract description 35
- 230000005284 excitation Effects 0.000 claims abstract description 93
- 230000036046 immunoreaction Effects 0.000 claims abstract description 49
- 230000008105 immune reaction Effects 0.000 claims abstract description 18
- 238000004879 turbidimetry Methods 0.000 claims abstract description 13
- 238000005286 illumination Methods 0.000 claims abstract description 3
- 239000012491 analyte Substances 0.000 claims description 120
- 239000003153 chemical reaction reagent Substances 0.000 claims description 67
- 239000000126 substance Substances 0.000 claims description 53
- 238000000034 method Methods 0.000 claims description 40
- 239000003085 diluting agent Substances 0.000 claims description 16
- 238000011088 calibration curve Methods 0.000 claims description 13
- 230000003287 optical effect Effects 0.000 claims description 12
- 238000007865 diluting Methods 0.000 claims description 9
- 238000005259 measurement Methods 0.000 claims description 8
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical group [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 5
- 229910052710 silicon Inorganic materials 0.000 claims description 5
- 239000010703 silicon Substances 0.000 claims description 5
- 230000005540 biological transmission Effects 0.000 claims description 3
- 238000011144 upstream manufacturing Methods 0.000 claims description 3
- 238000004458 analytical method Methods 0.000 claims description 2
- 238000012935 Averaging Methods 0.000 claims 1
- 238000000504 luminescence detection Methods 0.000 abstract description 5
- 239000000523 sample Substances 0.000 description 26
- 238000004020 luminiscence type Methods 0.000 description 19
- 239000003550 marker Substances 0.000 description 15
- 239000004005 microsphere Substances 0.000 description 11
- 238000012360 testing method Methods 0.000 description 8
- 230000008901 benefit Effects 0.000 description 6
- 239000000090 biomarker Substances 0.000 description 6
- 230000028993 immune response Effects 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- 239000004816 latex Substances 0.000 description 5
- 229920000126 latex Polymers 0.000 description 5
- 101000623895 Bos taurus Mucin-15 Proteins 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 3
- 208000035143 Bacterial infection Diseases 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 230000002238 attenuated effect Effects 0.000 description 2
- 208000022362 bacterial infectious disease Diseases 0.000 description 2
- 229960000074 biopharmaceutical Drugs 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000003018 immunoassay Methods 0.000 description 2
- 238000009776 industrial production Methods 0.000 description 2
- 238000009434 installation Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000009385 viral infection Effects 0.000 description 2
- 206010010071 Coma Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000005281 excited state Effects 0.000 description 1
- 238000001917 fluorescence detection Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000000891 luminescent agent Substances 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
- G01N21/76—Chemiluminescence; Bioluminescence
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/01—Arrangements or apparatus for facilitating the optical investigation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
- G01N21/77—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
- G01N21/82—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator producing a precipitate or turbidity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5302—Apparatus specially adapted for immunological test procedures
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Urology & Nephrology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Plasma & Fusion (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010347511.6A CN111413327B (zh) | 2020-04-28 | 2020-04-28 | 双模式检测***和双模式检测方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010347511.6A CN111413327B (zh) | 2020-04-28 | 2020-04-28 | 双模式检测***和双模式检测方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111413327A true CN111413327A (zh) | 2020-07-14 |
CN111413327B CN111413327B (zh) | 2023-03-21 |
Family
ID=71492163
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010347511.6A Active CN111413327B (zh) | 2020-04-28 | 2020-04-28 | 双模式检测***和双模式检测方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111413327B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112179859A (zh) * | 2020-09-30 | 2021-01-05 | 华兰基因工程有限公司 | 一种定量检测肺炎球菌多糖含量的免疫学检测方法 |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06148203A (ja) * | 1992-11-11 | 1994-05-27 | Toshiba Corp | 自動分析装置 |
US6042785A (en) * | 1996-04-22 | 2000-03-28 | Wallac Oy | Multilabel measurement instrument |
CN1428603A (zh) * | 2001-12-22 | 2003-07-09 | 浙江大学 | 荧光余辉测量装置 |
US6825921B1 (en) * | 1999-11-10 | 2004-11-30 | Molecular Devices Corporation | Multi-mode light detection system |
US20150044780A1 (en) * | 2012-04-26 | 2015-02-12 | Roche Diagnostics Operations, Inc. | Multi-application approach for photometric determination of an analyte in a fluid sample on an automated analyzer |
CN204389386U (zh) * | 2015-01-05 | 2015-06-10 | 任峰 | 一种多光谱透射、散射比浊法和化学发光反射法检测用检测头及检测浊度仪 |
CN207396345U (zh) * | 2017-03-21 | 2018-05-22 | 广州埃克森生物科技有限公司 | 一种poct特定蛋白检测分析仪 |
CN109100341A (zh) * | 2018-08-27 | 2018-12-28 | 绿嘉图(北京)科技有限公司 | 一种多功能干式poct设备及检测方法 |
CN208547572U (zh) * | 2018-05-15 | 2019-02-26 | 三诺生物传感股份有限公司 | 一种可兼容比色、比浊和荧光检测的光学*** |
-
2020
- 2020-04-28 CN CN202010347511.6A patent/CN111413327B/zh active Active
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06148203A (ja) * | 1992-11-11 | 1994-05-27 | Toshiba Corp | 自動分析装置 |
US6042785A (en) * | 1996-04-22 | 2000-03-28 | Wallac Oy | Multilabel measurement instrument |
US6825921B1 (en) * | 1999-11-10 | 2004-11-30 | Molecular Devices Corporation | Multi-mode light detection system |
CN1428603A (zh) * | 2001-12-22 | 2003-07-09 | 浙江大学 | 荧光余辉测量装置 |
US20150044780A1 (en) * | 2012-04-26 | 2015-02-12 | Roche Diagnostics Operations, Inc. | Multi-application approach for photometric determination of an analyte in a fluid sample on an automated analyzer |
CN204389386U (zh) * | 2015-01-05 | 2015-06-10 | 任峰 | 一种多光谱透射、散射比浊法和化学发光反射法检测用检测头及检测浊度仪 |
CN207396345U (zh) * | 2017-03-21 | 2018-05-22 | 广州埃克森生物科技有限公司 | 一种poct特定蛋白检测分析仪 |
CN208547572U (zh) * | 2018-05-15 | 2019-02-26 | 三诺生物传感股份有限公司 | 一种可兼容比色、比浊和荧光检测的光学*** |
CN109100341A (zh) * | 2018-08-27 | 2018-12-28 | 绿嘉图(北京)科技有限公司 | 一种多功能干式poct设备及检测方法 |
Non-Patent Citations (1)
Title |
---|
吴雪梅: "降钙素原及C反应蛋白在儿科感染性疾病中的临床价值", 《中华医院感染学杂志》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112179859A (zh) * | 2020-09-30 | 2021-01-05 | 华兰基因工程有限公司 | 一种定量检测肺炎球菌多糖含量的免疫学检测方法 |
Also Published As
Publication number | Publication date |
---|---|
CN111413327B (zh) | 2023-03-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20210389316A1 (en) | System and apparatus for point-of-care diagnostics | |
US20210293793A1 (en) | Interactive test device and apparatus with timing mechanism | |
CN101592659B (zh) | 一种基于持续荧光物标记的试条定量检测***及其方法 | |
US4421860A (en) | Homogeneous fluoroimmunoassay involving autocorrelation processing of optically sensed signals | |
JP6861642B2 (ja) | 蛍光検出のための方法およびシステム | |
US4407964A (en) | Homogeneous fluoroimmunoassay involving sensing radiation for forward and back directions | |
CN201535776U (zh) | 基于持续荧光物标记的试条定量检测*** | |
EP2841926B1 (en) | Biological assay sample analyzer | |
CN107576802A (zh) | 一种荧光微量蛋白的检测装置及检测方法 | |
CN111413327B (zh) | 双模式检测***和双模式检测方法 | |
CN112955742A (zh) | 一种血样分析方法及凝血分析仪 | |
US7528952B2 (en) | Hand-held fluorescence polarimeter | |
CN115244382A (zh) | 一种样本分析方法和装置 | |
CN115244403A (zh) | 一种样本分析装置及方法 | |
CN115280155A (zh) | 一种样本分析装置及方法 | |
CN205786658U (zh) | 基于单频激发双频接收原理的免疫层析检测*** | |
CN104897635A (zh) | 免疫荧光分析仪 | |
CN111505267B (zh) | 一种时间分辨免疫分析检测***与检测方法 | |
Rajulu et al. | Principles of Quantitative Estimation of Drugs, Endogenous Compounds, and Poisons—2 | |
Soini et al. | Time-resolved fluoroimmunoassay | |
Rocks | Light absorption, scatter and luminescence techniques in routine clinical biochemistry | |
Spectrophotometry | Basic and Contemporary Techniques in the Clinical Laboratory |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20220315 Address after: 200438 room 904b, block A8, WANGU Science Park, Guoquan North Road, Yangpu District, Shanghai Applicant after: Shanghai Taihui Biotechnology Co.,Ltd. Applicant after: Zhongshan Taihui Biotechnology Co.,Ltd. Address before: 200438 room 904b, block A8, WANGU Science Park, Guoquan North Road, Yangpu District, Shanghai Applicant before: Shanghai Taihui Biotechnology Co.,Ltd. Applicant before: Zhongshan Taihui Biotechnology Co.,Ltd. Applicant before: Shenzhen Taihui Biotechnology Co.,Ltd. Applicant before: Shijiazhuang Dihong Biotechnology Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240410 Address after: Room 302, 303, and 308, 3rd Floor, Building 2, No. 18 Chunchang Road, Minhang District, Shanghai, 201108 Patentee after: Shanghai Taihui Biotechnology Co.,Ltd. Country or region after: China Address before: 200438 room 904b, block A8, WANGU Science Park, Guoquan North Road, Yangpu District, Shanghai Patentee before: Shanghai Taihui Biotechnology Co.,Ltd. Country or region before: China Patentee before: Zhongshan Taihui Biotechnology Co.,Ltd. |
|
TR01 | Transfer of patent right |